1. Biomimetic nanoparticles for cancer vaccines and immunotherapy: mechanisms, tumor microenvironment reprogramming, and translational perspectives
Shahab Ms, Azizuddin S, Aslam M, Haque Mw, Ahsan Mn, Snigdha Nt, Et Al.
Biomimetic nanoparticles (BMNPs) have emerged as promising platforms for cancer vaccines and immunotherapy by combining nanoscale delivery systems with biological interfaces derived from cells or extracellular vesicles (EVs). Their therapeutic behavior is influenced by the biological source, surface composition…
Read the article